PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
WST vs. ABBV
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


WSTABBV
YTD Return-4.96%3.27%
1Y Return-2.27%17.90%
3Y Return (Ann)0.31%15.64%
5Y Return (Ann)23.91%19.76%
10Y Return (Ann)23.43%15.97%
Sharpe Ratio-0.150.86
Daily Std Dev30.05%18.41%
Max Drawdown-55.52%-45.09%
Current Drawdown-28.66%-12.95%

Fundamentals


WSTABBV
Market Cap$26.03B$293.88B
EPS$7.58$3.36
PE Ratio46.9249.53
PEG Ratio6.720.45
Revenue (TTM)$2.93B$54.40B
Gross Profit (TTM)$1.14B$41.53B
EBITDA (TTM)$809.60M$26.12B

Correlation

-0.50.00.51.00.3

The correlation between WST and ABBV is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

WST vs. ABBV - Performance Comparison

In the year-to-date period, WST achieves a -4.96% return, which is significantly lower than ABBV's 3.27% return. Over the past 10 years, WST has outperformed ABBV with an annualized return of 23.43%, while ABBV has yielded a comparatively lower 15.97% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


600.00%800.00%1,000.00%1,200.00%1,400.00%1,600.00%December2024FebruaryMarchAprilMay
1,196.16%
616.30%
WST
ABBV

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


West Pharmaceutical Services, Inc.

AbbVie Inc.

Risk-Adjusted Performance

WST vs. ABBV - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for West Pharmaceutical Services, Inc. (WST) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


WST
Sharpe ratio
The chart of Sharpe ratio for WST, currently valued at -0.06, compared to the broader market-2.00-1.000.001.002.003.004.00-0.06
Sortino ratio
The chart of Sortino ratio for WST, currently valued at 0.13, compared to the broader market-4.00-2.000.002.004.006.000.13
Omega ratio
The chart of Omega ratio for WST, currently valued at 1.02, compared to the broader market0.501.001.502.001.02
Calmar ratio
The chart of Calmar ratio for WST, currently valued at -0.05, compared to the broader market0.002.004.006.00-0.05
Martin ratio
The chart of Martin ratio for WST, currently valued at -0.16, compared to the broader market-10.000.0010.0020.0030.00-0.16
ABBV
Sharpe ratio
The chart of Sharpe ratio for ABBV, currently valued at 0.86, compared to the broader market-2.00-1.000.001.002.003.004.000.86
Sortino ratio
The chart of Sortino ratio for ABBV, currently valued at 1.24, compared to the broader market-4.00-2.000.002.004.006.001.24
Omega ratio
The chart of Omega ratio for ABBV, currently valued at 1.17, compared to the broader market0.501.001.502.001.17
Calmar ratio
The chart of Calmar ratio for ABBV, currently valued at 0.76, compared to the broader market0.002.004.006.000.76
Martin ratio
The chart of Martin ratio for ABBV, currently valued at 3.22, compared to the broader market-10.000.0010.0020.0030.003.22

WST vs. ABBV - Sharpe Ratio Comparison

The current WST Sharpe Ratio is -0.15, which is lower than the ABBV Sharpe Ratio of 0.86. The chart below compares the 12-month rolling Sharpe Ratio of WST and ABBV.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.00December2024FebruaryMarchAprilMay
-0.06
0.86
WST
ABBV

Dividends

WST vs. ABBV - Dividend Comparison

WST's dividend yield for the trailing twelve months is around 0.24%, less than ABBV's 3.86% yield.


TTM20232022202120202019201820172016201520142013
WST
West Pharmaceutical Services, Inc.
0.24%0.22%0.31%0.15%0.23%0.41%0.58%0.54%0.58%0.75%0.77%0.78%
ABBV
AbbVie Inc.
3.86%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%3.03%

Drawdowns

WST vs. ABBV - Drawdown Comparison

The maximum WST drawdown since its inception was -55.52%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for WST and ABBV. For additional features, visit the drawdowns tool.


-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%December2024FebruaryMarchAprilMay
-28.66%
-12.95%
WST
ABBV

Volatility

WST vs. ABBV - Volatility Comparison

The current volatility for West Pharmaceutical Services, Inc. (WST) is 5.83%, while AbbVie Inc. (ABBV) has a volatility of 6.45%. This indicates that WST experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%December2024FebruaryMarchAprilMay
5.83%
6.45%
WST
ABBV

Financials

WST vs. ABBV - Financials Comparison

This section allows you to compare key financial metrics between West Pharmaceutical Services, Inc. and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items